Valuation: Inotiv, Inc.

Market Cap 419K 367K 338K 317K 594K 39.49M 606K 4.07M 1.57M 19.52M 1.57M 1.54M 67.68M P/E 2024
-0.41x
P/E 2025 -0.69x
Enterprise Value 438M 384M 354M 331M 621M 41.31B 634M 4.25B 1.65B 20.42B 1.64B 1.61B 70.8B EV / Sales 2024
0.95x
EV / Sales 2025 0.95x
Free-Float
91.32%
Yield 2024 *
-
Yield 2025 -
1 day+48.15%
1 week-17.24%
Current month-95.80%
1 month-95.50%
3 months-95.60%
6 months-98.03%
Current year-97.87%
1 week 0.01
Extreme 0.007
0.02
1 month 0.01
Extreme 0.007
0.32
Current year 0.01
Extreme 0.007
0.65
1 year 0.01
Extreme 0.007
2.44
3 years 0.01
Extreme 0.007
11.42
5 years 0.01
Extreme 0.007
60.66
10 years 0.01
Extreme 0.007
60.66
Manager TitleAgeSince
Chief Executive Officer 67 11/01/2019
Director of Finance/CFO 61 05/03/2020
Compliance Officer 49 22/10/2023
Director TitleAgeSince
Chairman 71 25/03/2024
Director/Board Member 60 01/07/2018
Director/Board Member 67 11/01/2019
Date Insider Type Main position Quantity % Market Cap.
06-17Tax

Chief Operating Officer

-5,769 0.0165%
06-17Tax

Executive/Senior Manager

-5,371 0.0154%
06-17Tax

Compliance Officer

-5,800 0.0166%
Change 5-day change 1-year change 3-year change Capi.($)
+48.15%-17.24%-99.35%-99.76% 419K
-0.48%+7.20%-5.08%+2.45% 46.2B
+2.19%+11.71%+385.81%+632.13% 38.71B
+2.53%+13.93%+20.85%-10.61% 31.9B
+1.65%+3.61%+9.98%+55.42% 31.12B
-4.16%-2.58%+8.74%+15.22% 23.77B
-0.32%+12.96% - - 16.2B
+1.37%+14.53%+71.80%+134.14% 15.05B
+1.00%+10.30%+13.31%+22.84% 13.74B
+3.63%+9.53%+104.07%+107.62% 13.42B
Average +5.56%+6.50%+56.68%+95.49% 23.01B
Weighted average by Cap. +0.75%+8.71%+86.69%+140.75%

Financials

2024 2025
Net sales 491M 430M 397M 371M 696M 46.29B 711M 4.77B 1.84B 22.88B 1.84B 1.8B 79.33B 513M 450M 415M 388M 728M 48.39B 743M 4.98B 1.93B 23.92B 1.93B 1.88B 82.94B
Net income -108M -95.08M -87.65M -82.05M -154M -10.23B -157M -1.05B -408M -5.06B -407M -398M -17.53B -68.62M -60.17M -55.46M -51.93M -97.37M -6.47B -99.39M -667M -258M -3.2B -258M -252M -11.09B
Net Debt 424M 371M 342M 321M 601M 39.97B 614M 4.12B 1.59B 19.75B 1.59B 1.56B 68.49B 438M 384M 354M 331M 621M 41.27B 634M 4.25B 1.64B 20.4B 1.64B 1.61B 70.73B
Logo Inotiv, Inc.
Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
Employees
1,996
Date Price Change Volume
26/06/26 US$0.0120 +48.15% 402,849
25/06/26 US$0.008100 -19.00% 173,562
24/06/26 US$0.0100 -9.91% 562,107
23/06/26 US$0.0111 -4.72% 543,410
22/06/26 US$0.0117 -19.66% 569,554
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOTVQ Stock